about
Coronary heart disease risk factors and outcomes in the twenty-first century: findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) StudyThe association of statin use and statin type and cognitive performance: analysis of the reasons for geographic and racial differences in stroke (REGARDS) study.Effect of atorvastatin on cognitive function in patients from the Lipid Lowering and Onset of Renal Disease (LORD) trial.The involvement of lipid rafts in Alzheimer's disease.Cholesterol, statins and tau.Atorvastatin attenuates the production of IL-1β, IL-6, and TNF-α in the hippocampus of an amyloid β1-42-induced rat model of Alzheimer's diseaseNeurocognitive enhancement: ethical considerations for an emerging subspecialty.Role of Lipids in Brain Injury and Diseases.Age-related influence of the HDL receptor SR-BI on synaptic plasticity and cognition.Altered lipid metabolism in brain injury and disorders.Cognitive effects of statin medications.Sex and Race Differences in the Association Between Statin Use and the Incidence of Alzheimer Disease.Pitavastatin, a new HMG-CoA reductase inhibitor, induces phototoxicity in human keratinocytes NCTC-2544 through the formation of benzophenanthridine-like photoproducts.Mechanisms of statin-mediated inhibition of small G-protein function.Simvastatin prevents the inflammatory process and the dopaminergic degeneration induced by the intranigral injection of lipopolysaccharide.A pivotal role for interleukin-4 in atorvastatin-associated neuroprotection in rat brain.Nobiletin-rich Citrus reticulata peels, a kampo medicine for Alzheimer's disease: a case series.Drug delivery to the brain: how can nanoencapsulated statins be used in the clinic?
P2860
Q27026525-E728600C-96AF-4B5D-8E0F-0E94E4264C1AQ34078486-4F1DD68E-1592-4D93-93CD-B348727F84B6Q34606331-6761CDAF-4313-4300-9A92-9A9563BEAAF5Q36447798-E27E15A8-39C1-4985-B0E6-AC2C2EE2C165Q36546527-8B1609F0-3AA8-4017-886C-C356BEAFE7C9Q36584677-DD6BD7D1-2F62-46F3-9AB8-F7007A84721DQ36607260-922977B0-C378-42DB-B706-F53458B209CDQ37051065-056DBFD6-ACA8-40BC-A2A8-47168D86EEE4Q37149894-7865ED05-99DF-48DE-890D-5D60AA91990FQ37254313-1452D698-219F-4A4E-8746-FD00F182DE0CQ38185988-8A389F7A-382B-4CCE-A644-E7E3667D4C81Q39109470-7D68CEB6-ED5B-442C-9762-39296330A120Q39450786-98AEE97C-A02C-405D-8784-C5B5245AA28FQ40387534-676340BF-147E-4B2B-AF09-A69965D08192Q46875236-0A231C30-D1EB-4C1A-8535-2D3F1A50680EQ46915325-02629131-ACCC-430E-ACF0-A3AFFA7E02E5Q47797247-6DDE3884-236E-4CDD-9D57-797E76F60A69Q48185768-F89AD297-4818-485D-9A4A-7C3882E04374
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Do statins slow down Alzheimer's disease? A review.
@ast
Do statins slow down Alzheimer's disease? A review.
@en
type
label
Do statins slow down Alzheimer's disease? A review.
@ast
Do statins slow down Alzheimer's disease? A review.
@en
prefLabel
Do statins slow down Alzheimer's disease? A review.
@ast
Do statins slow down Alzheimer's disease? A review.
@en
P2860
P1476
Do statins slow down Alzheimer's disease? A review.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2710.2004.00560.X
P577
2004-06-01T00:00:00Z